A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results

Affiliations

• ¹ National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. uralcytometry@gmail.com.
• ² Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• ³ National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
• ⁴ Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
• ⁵ Regional Children's Hospital, Ekaterinburg, Russian Federation.
• ⁶ Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
• ⁷ Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation.
• ⁸ Republican Children's Hospital, Moscow, Russian Federation.